Dose-finding study of oral estetrol for vasomotor symptoms in postmenopausal women

Phase 2, randomised, double-blind trial in vasomotor symptoms and vaginal atrophy comparing Estetrol with Placebo (2 arms). Primary endpoints: Change in weekly frequency of moderate to severe vasomotor symptoms from baseline to week 4, Change in weekly frequency of moderate to severe vasomotor symptoms from baseline to week 12 and 2 more. Started Apr 2016; status: active, not recruiting.